Long Covid: a global health issue – a prospective, cohort study set in four continents
Authors:
- Ekaterina PazukhinaEPEkaterina Pazukhina
- Esteban Garcia-GalloEGEsteban Garcia-Gallo
- Luis Felipe ReyesLRLuis Felipe Reyes
- Anders Benjamin KildalAKAnders Benjamin Kildal
- Waasila JassatWJWaasila Jassat
- Murray DrydenMDMurray Dryden
- Jan Cato HolterJHJan Cato Holter
- Allegra ChatterjeeACAllegra Chatterjee
- Kyle GomezKGKyle Gomez
- Arne SøraasASArne Søraas
- Matteo PuntoniMPMatteo Puntoni
- Nicola LatronicoNLNicola Latronico
Open Access
- 21 October 2024
- journal article
- research article
- Published by BMJ in BMJ Global Health
- Vol. 9 (10) , e015245
Abstract
Introduction A proportion of people develop Long Covid after acute COVID-19, but with most studies concentrated in high-income countries (HICs), the global burden is largely unknown. Our study aims to characterise long-term COVID-19 sequelae in populations globally and compare the prevalence of reported symptoms in HICs and low-income and middle-income countries (LMICs). Methods A prospective, observational study in 17 countries in Africa, Asia, Europe and South America, including adults with confirmed COVID-19 assessed at 2 to Results Of 11 860 participants (median age: 52 (IQR: 41–62) years; 52.1% females), 56.5% were from HICs and 43.5% were from LMICs. The proportion identified with Long Covid was significantly higher in HICs vs LMICs at both assessment time points (69.0% vs 45.3%, pConclusion Our data show that Long Covid affects populations globally, manifesting similar symptomatology and impact on functioning in both HIC and LMICs. The prevalence was higher in HICs versus LMICs. Although we identified a lower prevalence, the impact of Long Covid may be greater in LMICs if there is a lack of support systems available in HICs. Further research into the aetiology of Long Covid and the burden in LMICs is critical to implement effective, accessible treatment and support strategies to improve COVID-19 outcomes for all.Keywords
This publication has 32 references indexed in Scilit:
- Core outcome measurement instruments for use in clinical and research settings for adults with post-COVID-19 condition: an international Delphi consensus studyThe Lancet Respiratory Medicine, 2023
- Long COVID in low-income and middle-income countries: the hidden public health crisisThe Lancet, 2023
- Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registryResearch and Practice in Thrombosis and Haemostasis, 2023
- Major adverse cardiovascular events (MACE) in patients with severe COVID-19 registered in the ISARIC WHO clinical characterization protocol: A prospective, multinational, observational studyJournal of Critical Care, 2023
- Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controlsThe Lancet Regional Health - Europe, 2023
- Long-term physical impairments in survivors of COVID-19-associated ARDS compared with classic ARDS: A two-center studyJournal of Critical Care, 2023
- COVID-19 long-term sequelae: Omicron versus Alpha and Delta variantsInfectious Diseases Now, 2023
- A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participantsInternational Journal of Infectious Diseases, 2022
- Long COVID: aiming for a consensusThe Lancet Respiratory Medicine, 2022
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009